Obstructive sleep apnea and the risk of autoimmune diseases: A longitudinal population-based study

Sleep Medicine

Volumn 13, Issue 6, 2012, Pages 583-588

  Kang, Jiunn Horng ^a,b   Lin, Herng Ching ^c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ankylosing spondylitis; Autoimmune disease; Inflammation; Obstructive sleep apnea; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SOCIOECONOMIC FACTORS; SPONDYLITIS, ANKYLOSING; TAIWAN;

EID: 84861926841     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.03.002     Document Type: Article

References (41)

1. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
2. Flemons W.W. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002, 347:498-504.
3. Marshall N.S., Wong K.K., Liu P.Y., Cullen S.R., Knuiman M.W., Grunstein R.R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton health study. Sleep 2008, 31:1079-1085.
4. Shochat T., Pillar G. Sleep apnoea in the older adult: pathophysiology, epidemiology, consequences and management. Drugs Aging 2003, 20:551-560.
5. Patil S.P., Schneider H., Schwartz A.R., Smith P.L. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007, 132:325-337.
6. McNicholas W.T. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 2009, 51:392-399.
7. Wolf J., Lewicka J., Narkiewicz K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis 2007, 17:233-240.
8. Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med 2009, 10(Suppl 1):S12-S16.
9. Garvey J.F., Taylor C.T., McNicholas W.T. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009, 33:1195-1205.
10. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 2009, 64:631-636.
11. Hatipoglu U., Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003, 70:665-671.
12. Zamarron C., Garcia Paz V., Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 2008, 19:390-398.
13. Kim E.Y., Moudgil K.D. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol Lett 2008, 120:1-5.
14. Silman A.J., Pearson J.E. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002, 4(Suppl. 3):S265-S272.
15. Erden S., Cagatay T., Buyukozturk S., Kiyan E., Cuhadaroglu C. Hashimoto thyroiditis and obstructive sleep apnea syndrome: is there any relation between them?. Eur J Med Res 2004, 9:570-572.
16. Quera-Salva M.A., Guilleminault C., Chevret S., Troche G., Fromageot C., Crowe McCann C., et al. Breathing disorders during sleep in myasthenia gravis. Ann Neurol 1992, 31:86-92.
17. Apostolaki M., Armaka M., Victoratos P., Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun 2010, 11:1-26.
18. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991, 10:4025-4031.
19. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA 1995, 92:11294-11298.
20. Abrams B. Long-term sleep apnea as a pathogenic factor for cell-mediated autoimmune disease. Med Hypotheses 2005, 65:1024-1027.
21. Li X., Sundquist K., Sundquist J. Socioeconomic status and occupation as risk factors for obstructive sleep apnea in Sweden: a population-based study. Sleep Med 2008, 9:129-136.
22. Shapira Y., Agmon-Levin N., Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010, 6:468-476.
23. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
24. Taylor P.C., Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:578-582.
25. Williams E.L., Gadola S., Edwards C.J. Anti-TNF-induced lupus. Rheumatology (Oxford) 2009, 48:716-720.
26. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005, 112:2660-2667.
27. Lavie L., Polotsky V. Cardiovascular aspects in obstructive sleep apnea syndrome - molecular issues, hypoxia and cytokine profiles. Respiration 2009, 78:361-370.
28. Minoguchi K., Tazaki T., Yokoe T., Minoguchi H., Watanabe Y., Yamamoto M., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004, 126:1473-1479.
29. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997, 82:1313-1316.
30. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160.
31. Mori L., Iselin S., De Libero G., Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol 1996, 157:3178-3182.
32. Ye L., Ma G.H., Chen L., Li M., Liu J.l., Yang K., et al. Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 2010, 188:469-474.
33. Morel P.A., Feili-Hariri M., Coates P.T., Thomson A.W. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol 2003, 133:1-10.
34. Hersoug L.G., Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance?. Allergy 2007, 62:1205-1213.
35. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919. quiz 920.
36. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009, 43:157-168.
37. Riha R.L., Brander P., Vennelle M., McArdle N., Kerr S.M., Anderson N.H., et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005, 26:673-678.
38. Hajeer A.H., Hutchinson I.V. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 2000, 50:216-228.
39. Cheng C.L., Kao Y.H., Lin S.J., Lee C.H., Lai M.L. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011, 20:236-242.
40. Lin H.C., Xirasagar S., Chen C.H., Hwang Y.T. Physician's case volume of intensive care unit pneumonia admissions and in-hospital mortality. Am J Respir Crit Care Med 2008, 177:989-994.
41. Chen Y.K., Lin H.C., Chen C.S., Yeh S.D. Seasonal variations in urinary calculi attacks and their association with climate: a population based study. J Urol 2008, 179:564-569.